<DOC>
	<DOCNO>NCT02636387</DOCNO>
	<brief_summary>This study assess use medication desmopressin decrease nightime bedwetting child sickle cell disease . Half child receive placebo half child receive desmopressin , option prescribe desmopressin soon study complete .</brief_summary>
	<brief_title>Desmopressin Therapy Bedwetting Children With Sickle Cell Disease</brief_title>
	<detailed_description>Night time bedwetting common complication sickle cell disease , affect 30 % child . Desmopressin oral medication increase water reabsorption kidney . Studies show effective decrease bedwetting episode child without sickle cell disease . Chronic sickling episode cause damage kidney could cause permanent damage may make treatment ineffective sickle cell disease . The investigator design trial definitively answer question randomize patient give half child placebo half titrated dos desmopressin . This trial inform pediatric sickle cell doctor desmopressin appropriate treatment bed wetting investigator patient .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Nocturnal Enuresis</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>1 . Patients Hemoglobin SS , SC , SB0thal SB+thal 2 . Patients least two episode primary nocturnal enuresis per week four episode two week prior enrollment . 3 . Patients secondary enuresis evaluate cleared pediatric urologist etiology enuresis ( e.g . overactive detrusor activity , genitourinary anatomic abnormality ) 1 . Patients developmental delay neurologic dysfunction secondary stroke . 2 . Patients hypertension underlie renal disease . 3 . Patients genitourinary anatomic abnormality . Any prior renal ultrasound show normal genitourinary anatomy sufficient clear patient study . 4 . Patients daytime urinary incontinence 5 . Patients glucosuria urinalysis . 6 . Patients secondary nocturnal enuresis evaluate pediatric urologist rule etiology enuresis . 7 . Patients pregnant . 8 . Patients receive another medicine nocturnal enuresis ( e.g . imipramine ) .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>